Sign inGet started

De Backer Marianne

Insider CIK 1797819 · VIR President and CEO, Director · KRON Director · ARWR Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
VIR Vir Biotechnology, Inc. J Other2026-04-292026-04-30233,532— $0286,650SEC↗
VIR Vir Biotechnology, Inc. J Other2026-04-292026-04-30233,532— $0714,613SEC↗
VIR Vir Biotechnology, Inc. S Sale2026-04-062026-04-0772,559$9.16 $664.6K948,145SEC↗
VIR Vir Biotechnology, Inc. S Sale2026-02-242026-02-2614,762$9.53 $140.7K1,020,704SEC↗
VIR Vir Biotechnology, Inc. S Sale2026-02-232026-02-2419,039$7.45 $141.8K1,035,466SEC↗
VIR Vir Biotechnology, Inc. A Award deriv2026-02-222026-02-24570,000— $0570,000SEC↗
VIR Vir Biotechnology, Inc. A Award2026-02-222026-02-24285,000— $01,054,505SEC↗
VIR Vir Biotechnology, Inc. S Sale2025-04-032025-04-0479,712$5.95 $474.3K769,505SEC↗
VIR Vir Biotechnology, Inc. S Sale2025-02-242025-02-2516,122$9.45 $152.4K849,217SEC↗
VIR Vir Biotechnology, Inc. A Award deriv2025-02-222025-02-25480,000— $0480,000SEC↗
VIR Vir Biotechnology, Inc. A Award2025-02-222025-02-25240,000— $0865,339SEC↗
VIR Vir Biotechnology, Inc. J Other2024-06-122024-06-1253,118— $053,118SEC↗
VIR Vir Biotechnology, Inc. J Other2024-06-122024-06-1253,118— $0625,339SEC↗
VIR Vir Biotechnology, Inc. S Sale2024-04-032024-04-0472,995$9.46 $690.5K678,457SEC↗
VIR Vir Biotechnology, Inc. A Award deriv2024-02-222024-02-26350,000— $0350,000SEC↗
VIR Vir Biotechnology, Inc. A Award2024-02-222024-02-26175,000— $0751,452SEC↗
KRON Kronos Bio, Inc. A Award deriv2023-06-222023-06-2634,000— $034,000SEC↗
VIR Vir Biotechnology, Inc. A Award deriv2023-04-032023-04-041,152,904— $01,152,904SEC↗
VIR Vir Biotechnology, Inc. A Award2023-04-032023-04-04576,452— $0576,452SEC↗
ARWR ARROWHEAD PHARMACEUTICALS, A Award deriv2023-01-102023-01-114,593— $04,593SEC↗
ARWR ARROWHEAD PHARMACEUTICALS, A Award2023-01-102023-01-117,867— $031,267SEC↗
KRON Kronos Bio, Inc. A Award deriv2022-06-222022-06-2917,000— $017,000SEC↗
KRON Kronos Bio, Inc. A Award2022-06-222022-06-2911,333— $014,083SEC↗
ARWR ARROWHEAD PHARMACEUTICALS, A Award2022-01-072022-01-076,400— $023,400SEC↗
ARWR ARROWHEAD PHARMACEUTICALS, S Sale2022-01-032022-01-04272$66.25 $18.0K17,000SEC↗
ARWR ARROWHEAD PHARMACEUTICALS, S Sale2022-01-032022-01-042,244$64.25 $144.2K19,256SEC↗
ARWR ARROWHEAD PHARMACEUTICALS, S Sale2022-01-032022-01-041,984$65.01 $129.0K17,272SEC↗
KRON Kronos Bio, Inc. P Buy2021-12-012021-12-021,150$11.57 $13.3K2,750SEC↗
KRON Kronos Bio, Inc. P Buy2021-08-202021-08-24500$19.50 $9.8K1,100SEC↗
KRON Kronos Bio, Inc. P Buy2021-08-202021-08-24500$19.63 $9.8K1,600SEC↗
ARWR ARROWHEAD PHARMACEUTICALS, S Sale2021-06-242021-06-255,000$89.85 $449.3K21,500SEC↗
KRON Kronos Bio, Inc. A Award deriv2021-06-222021-06-238,583— $08,583SEC↗
KRON Kronos Bio, Inc. P Buy2021-05-282021-06-01600$25.01 $15.0K600SEC↗
KRON Kronos Bio, Inc. A Award deriv2021-01-252021-01-2741,200— $041,200SEC↗
ARWR ARROWHEAD PHARMACEUTICALS, A Award2021-01-012021-01-059,000— $026,500SEC↗
ARWR ARROWHEAD PHARMACEUTICALS, P Buy2020-10-082020-10-26500$50.93 $25.5K17,000SEC↗
ARWR ARROWHEAD PHARMACEUTICALS, P Buy2020-10-082020-10-26500$50.00 $25.0K17,500SEC↗
ARWR ARROWHEAD PHARMACEUTICALS, P Buy2020-06-152020-06-24500$31.33 $15.7K16,500SEC↗
ARWR ARROWHEAD PHARMACEUTICALS, P Buy2020-04-152020-06-24500$35.40 $17.7K16,000SEC↗
ARWR ARROWHEAD PHARMACEUTICALS, P Buy2020-03-162020-06-24500$23.94 $12.0K15,500SEC↗
ARWR ARROWHEAD PHARMACEUTICALS, P Buy2020-03-122020-06-24500$24.80 $12.4K15,000SEC↗
ARWR ARROWHEAD PHARMACEUTICALS, P Buy2020-03-112020-06-24500$28.60 $14.3K14,500SEC↗
ARWR ARROWHEAD PHARMACEUTICALS, P Buy2020-02-282020-06-24500$34.39 $17.2K14,000SEC↗
ARWR ARROWHEAD PHARMACEUTICALS, P Buy2020-02-272020-06-24500$35.07 $17.5K13,500SEC↗
ARWR ARROWHEAD PHARMACEUTICALS, P Buy2020-01-132020-06-24500$54.95 $27.5K13,000SEC↗
ARWR ARROWHEAD PHARMACEUTICALS, A Award2020-01-012020-01-037,500— $012,500SEC↗